EphB2 was reported to be expressed in benign tissues, but it was significantly upregulated in breast cancer, especially in invasive and metastatic carcinomas (Wu et al., 2004; Chukkapalli et al., 2014). This evidence concerns the gene EPHB2 and breast carcinoma.